Search / Trial NCT06230276

Managing of Missed Meal Bolus by HCL Systems

Launched by ZDENĚK ŠUMNÍK · Jan 19, 2024

Trial Information

Current as of October 04, 2024

Recruiting

Keywords

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * children with type 1 diabetes (CwD) 9.00-18.99 years old
  • * use of continuous glucose monitoring (CGM) \>70% of the time 14 days before a regular check-up in the outpatient clinic
  • * HCL use (MiniMed 780G, Tandem Control-IQ or Ypsomed CamAPS) \>3 months
  • * duration of T1D \>2 years
  • * baseline HbA1c level \<58 mmol/mol (7.5%)
  • * weight \> 30 kilograms
  • * without any medication influencing glycemia (f.e. gliflozins, systemic corticosteroids...)
  • * signed informed consent form with the study

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Prague, , Czechia

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0